Internal Medicine, Endocrinology, Diabetes, & Metabolism · New York, NY
NPI
1073627063
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
5 E 98th St
New York, NY, 10029
Phone (212) 241-7975
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
310 services
Medicare patients, 2024
199
Average age 71
Drug cost, 2024
$958K
715 prescriptions
Company payments, 2025
$95K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eliza B Geer was code 99214 (office e&m - established), 124 times for 96 patients. In total Eliza B Geer billed 310 services in 11 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 124 | 96 | $91.28 | $11K |
| 99213 Office E&M - Established | Office | 82 | 62 | $59.42 | $4,872 |
| 99215 Office E&M - Established | Office | 32 | 27 | $146.20 | $4,678 |
| 99205 Office E&M - New | Office | 23 | 23 | $163.71 | $3,765 |
| 99204 Office E&M - New | Office | 16 | 16 | $119.69 | $1,915 |
By year: 2022 $21K for 239 services; 2023 $20K for 238 services; 2024 $29K for 310 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eliza B Geer prescribed most often to Medicare patients was Hydrocortisone, with 174 prescriptions and refills. In total Eliza B Geer wrote 715 Medicare prescriptions that cost $958K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocortisone Generic | 174 | 404 | 64 | $12K |
| Levothyroxine Sodium Generic | 140 | 382 | 48 | $1,678 |
| Cabergoline Generic | 61 | 146 | 16 | $8,007 |
| Desmopressin Acetate Generic | 48 | 124 | 14 | $6,954 |
| Synthroid Levothyroxine Sodium | 46 | 112 | 11 | $3,351 |
| Isturisa Osilodrostat Phosphate | 41 | 45 | Under 11 | $703K |
| Testosterone Generic | 25 | 42 | Under 11 | $3,948 |
| Prednisone Generic | 24 | 66 | Under 11 | $419 |
| Genotropin Somatropin | 17 | 21 | Under 11 | $33K |
| Solu-Cortef Hydrocortisone Sodium Succ/Pf | 16 | 18 | 16 | $450 |
| Somavert Pegvisomant | 13 | 13 | Under 11 | $85K |
| Dexamethasone Generic | 12 | 12 | Under 11 | $5.45 |
| Insulin Syringe Syring-Needl,disp,insul,0.3 Ml | 11 | 16 | Under 11 | $333 |
Brand drugs: 219 claims; generic drugs: 480 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eliza B Geer $95K ($16K in general payments such as food, travel and fees and $80K for research) from 3 companies. The largest payer was Recordati_rare_diseases_inc. with $86K.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 13 | $86K |
| Xeris Pharmaceuticals, Inc. | 3 | $8,230 |
| Esteve Pharmaceuticals LLC | 1 | $654 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.